Two Sigma Securities’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1588 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1710 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1643 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1567 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1562 |
|
|
2023
Q3 | – | Sell |
-6,864
| Closed | -$385K | – | 1484 |
|
|
2023
Q2 | $385K | Buy |
+6,864
| New | +$385K | 0.01% | 437 |
|
|
2023
Q1 | – | Sell |
-15,501
| Closed | -$630K | – | 1456 |
|
|
2022
Q4 | $630K | Buy |
15,501
+4,981
| +47% | +$202K | 0.02% | 261 |
|
|
2022
Q3 | $687K | Buy |
10,520
+2,266
| +27% | +$148K | 0.02% | 263 |
|
|
2022
Q2 | $502K | Buy |
+8,254
| New | +$502K | 0.02% | 302 |
|
|
2022
Q1 | – | Sell |
-5,518
| Closed | -$418K | – | 1186 |
|
|
2021
Q4 | $418K | Buy |
+5,518
| New | +$418K | 0.02% | 314 |
|
|
2021
Q3 | – | Sell |
-1,537
| Closed | -$249K | – | 919 |
|
|
2021
Q2 | $249K | Buy |
+1,537
| New | +$249K | 0.01% | 423 |
|